Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host–Guest Complexes in a Comparative Evaluation
Peimanfard, S.; Zarrabi, A.; Trotta, F.; Matencio, A.; Cecone, C.; Caldera, F. Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host–Guest Complexes in a Comparative Evaluation. Pharmaceutics 2022, 14, 1059. https://doi.org/10.3390/pharmaceutics14051059
Peimanfard S, Zarrabi A, Trotta F, Matencio A, Cecone C, Caldera F. Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host–Guest Complexes in a Comparative Evaluation. Pharmaceutics. 2022; 14(5):1059. https://doi.org/10.3390/pharmaceutics14051059
Chicago/Turabian StylePeimanfard, Shohreh, Ali Zarrabi, Francesco Trotta, Adrián Matencio, Claudio Cecone, and Fabrizio Caldera. 2022. "Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host–Guest Complexes in a Comparative Evaluation" Pharmaceutics 14, no. 5: 1059. https://doi.org/10.3390/pharmaceutics14051059